These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 27938583)
21. Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study. Andriulli A; Caruso N; Quitadamo M; Forlano R; Leandro G; Spirito F; De Maio G JOP; 2003 Jan; 4(1):41-8. PubMed ID: 12555015 [TBL] [Abstract][Full Text] [Related]
22. Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic review. Choudhary A; Bechtold ML; Arif M; Szary NM; Puli SR; Othman MO; Pais WP; Antillon MR; Roy PK Gastrointest Endosc; 2011 Feb; 73(2):275-82. PubMed ID: 21295641 [TBL] [Abstract][Full Text] [Related]
23. Antisecretory agents for prevention of post-ERCP pancreatitis: rationale for use and clinical results. Poon RT; Fan ST JOP; 2003 Jan; 4(1):33-40. PubMed ID: 12555014 [TBL] [Abstract][Full Text] [Related]
24. Effect of somatostatin in the prevention of pancreatic complications after endoscopic retrograde cholangiopancreatography. Chan HH; Lai KH; Lin CK; Tsai WL; Lo GH; Hsu PI; Wei MC; Wang EM J Chin Med Assoc; 2008 Dec; 71(12):605-9. PubMed ID: 19114324 [TBL] [Abstract][Full Text] [Related]
25. Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial. Poon RT; Yeung C; Lo CM; Yuen WK; Liu CL; Fan ST Gastrointest Endosc; 1999 May; 49(5):593-8. PubMed ID: 10228257 [TBL] [Abstract][Full Text] [Related]
26. Glyceryl trinitrate for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: a meta-analysis of randomized, double-blind, placebo-controlled trials. Bai Y; Xu C; Yang X; Gao J; Zou DW; Li ZS Endoscopy; 2009 Aug; 41(8):690-5. PubMed ID: 19670137 [TBL] [Abstract][Full Text] [Related]
27. Is prophylactic somatostatin effective to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis or hyperamylasemia? A randomized, placebo-controlled pilot trial. Wang ZK; Yang YS; Cai FC; Wang YH; Shi XL; Ding C; Li W Chin Med J (Engl); 2013 Jul; 126(13):2403-8. PubMed ID: 23823808 [TBL] [Abstract][Full Text] [Related]
28. Somatostatin bolus injection for post-ERCP pancreatitis prevention: a need for further study. Rudin D Gastrointest Endosc; 2008 Jan; 67(1):190; author reply 190-1. PubMed ID: 18155442 [No Abstract] [Full Text] [Related]
29. Nonsteroidal anti-inflammatory drugs reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis. Li L; Han Z; Yuan H; Zhang G; Jia Y; He C J Hepatobiliary Pancreat Sci; 2017 Sep; 24(9):520-529. PubMed ID: 28681997 [TBL] [Abstract][Full Text] [Related]
30. Updated meta-analysis of pancreatic stent placement in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis. Fan JH; Qian JB; Wang YM; Shi RH; Zhao CJ World J Gastroenterol; 2015 Jun; 21(24):7577-83. PubMed ID: 26140006 [TBL] [Abstract][Full Text] [Related]
31. Meta-analysis of prophylactic allopurinol use in post-endoscopic retrograde cholangiopancreatography pancreatitis. Zheng M; Chen Y; Bai J; Xin Y; Pan X; Zhao L Pancreas; 2008 Oct; 37(3):247-53. PubMed ID: 18815544 [TBL] [Abstract][Full Text] [Related]
32. Effects of Somatostatin and Indomethacin Mono or Combination Therapy on High-risk Hyperamylasemia and Post-pancreatitis Endoscopic Retrograde Cholangiopancreatography Patients: A Randomized Study. Wu Z; Xiao G; Wang G; Xiong L; Qiu P; Tan S Surg Laparosc Endosc Percutan Tech; 2023 Oct; 33(5):474-479. PubMed ID: 37523580 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of gabexate mesilate in preventing post endoscopic retrograde cholangiopancreatography pancreatitis: A meta-analysis of randomized clinical trials. Chiu YJ; Chen SC; Kang YN; Hou SK; Chao CC; Chang CC J Formos Med Assoc; 2021 Apr; 120(4):1090-1099. PubMed ID: 33183879 [TBL] [Abstract][Full Text] [Related]
34. Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials. Zheng M; Chen Y; Yang X; Li J; Zhang Y; Zeng Q BMC Gastroenterol; 2007 Feb; 7():6. PubMed ID: 17295917 [TBL] [Abstract][Full Text] [Related]
35. Prophylactic corticosteroids do not prevent post-ERCP pancreatitis: a meta-analysis of randomized controlled trials. Bai Y; Gao J; Shi X; Zou D; Li Z Pancreatology; 2008; 8(4-5):504-9. PubMed ID: 18765955 [TBL] [Abstract][Full Text] [Related]
36. Rectal indomethacin for the prevention of post-ERCP pancreatitis: A meta-analysis of randomized controlled trials. Shi N; Deng L; Altaf K; Huang W; Xue P; Xia Q Turk J Gastroenterol; 2015 May; 26(3):236-40. PubMed ID: 26006198 [TBL] [Abstract][Full Text] [Related]
37. Rectal nonsteroidal anti-inflammatory drugs administration is effective for the prevention of post-ERCP pancreatitis: An updated meta-analysis of randomized controlled trials. Yang C; Zhao Y; Li W; Zhu S; Yang H; Zhang Y; Liu X; Peng N; Fan P; Jin X Pancreatology; 2017; 17(5):681-688. PubMed ID: 28734720 [TBL] [Abstract][Full Text] [Related]
38. Role of ulinastatin in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: the Emperor's New Clothes or Aladdin's Magic Lamp? Chen S; Shi H; Zou X; Luo H Pancreas; 2010 Nov; 39(8):1231-7. PubMed ID: 20531245 [TBL] [Abstract][Full Text] [Related]
39. Early Precut Sphincterotomy Does Not Increase Risk During Endoscopic Retrograde Cholangiopancreatography in Patients With Difficult Biliary Access: A Meta-analysis of Randomized Controlled Trials. Sundaralingam P; Masson P; Bourke MJ Clin Gastroenterol Hepatol; 2015 Oct; 13(10):1722-1729.e2. PubMed ID: 26144018 [TBL] [Abstract][Full Text] [Related]
40. Antioxidant supplementation for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials. Gu WJ; Wei CY; Yin RX Nutr J; 2013 Feb; 12():23. PubMed ID: 23398675 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]